Given what happened with the recent Sirtex study results, it'll be interesting to see how any results around alleviating pain/improving quality of life will be leveraged, as opposed to reduction in size of tumour and life expectancy.
Life expectancy is rubbish with these cancers and I'd have thought that improvement in quality of life will be an important outcome, even if life expectancy dial does not move significantly...
Given what happened with the recent Sirtex study results, it'll...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.23 |
Change
0.210(20.6%) |
Mkt cap ! $17.49M | |||
| Open | High | Low | Value | Volume |
| $1.05 | $1.24 | $1.03 | $200.2K | 169.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3500 | $1.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.25 | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 26/06/2025 (20 minute delay) ? |
| OSL (ASX) Chart |